Antibodies that bind gamma-heregulin

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S971000, C530S399000, C530S388230, C530S389100, C530S387100, C530S388100, C530S389200

Reexamination Certificate

active

06916624

ABSTRACT:
A novel member of the heregulin superfamily has been identified which is designated “γ-HRG”. This molecule, secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner. γ-HRG polypeptide and nucleic acid are disclosed, together with various uses therefor (e.g. use of γ-HRG nucleic acid for the recombinant production of γ-HRG). γ-HRG antagonists (e.g. neutralizing antibodies and antisense nucleic acid molecules) as well as uses therefor are also described.

REFERENCES:
patent: 4968603 (1990-11-01), Slamon et al.
patent: 5183884 (1993-02-01), Kraus et al.
patent: 5367060 (1994-11-01), Vandlen et al.
patent: 444961 (1991-09-01), None
patent: 505148 (1992-09-01), None
patent: 0599274 (1994-06-01), None
patent: WO 92/18627 (1992-10-01), None
patent: WO 92/20798 (1992-11-01), None
patent: WO 93/16178 (1993-08-01), None
patent: WO 93/22424 (1993-11-01), None
patent: WO 94/00140 (1994-01-01), None
patent: WO 94/04560 (1994-03-01), None
patent: WO 94/08007 (1994-04-01), None
patent: WO 94/26298 (1994-11-01), None
patent: WO 94/28133 (1994-12-01), None
patent: WO 95/02052 (1995-01-01), None
patent: WO 95/32724 (1995-07-01), None
patent: WO 98/02541 (1998-01-01), None
Ben-Zur et al, Dev. Biol 217:107-120, (2000).
Adams et al., “Sequence identification of 2,375 human brain genes”Nature355:632-634 (Feb. 1992).
Beerli et al., “Neu Differentiation Factor Activation of ErbB-3 and ErbB-4 is Cell Specific and Displays a Differential Requirement for ErbB-2”Molecular&Cellular Biology15:6496-6505 (Dec. 1995).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”Science247:1306-1310 (1990).
Brockes et al., “Glial growth factor-like activity in Schwann Cell tumors”Annals of Neurology20:317-322 (1986).
Brockes et al., “Purification and preliminary characterization of a glial growth factor from the bovine pituitary”Journal of Biological Chemistry255(18):8374-8377 (1980).
Brockes, “Assay and isolation of glial growth factor from the bovine pituitary”Methods in Enzymology147:217-225 (1987).
Carraway and Cantley., “A Neu Acquaintance for ErbB3 and ErbB4: A Role for Receptor Heterodimerization in Growth Signaling.”Cell78:5-8 (Jul. 15, 1994).
Carraway et al., “The erbB3 gene product is a receptor for heregulin”Journal of Biological Chemistry269(19):14303-14306 (1994).
Chomczynski et al., “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction”Analytical Biochemistry162(1):156-159 (Apr. 1987).
Corfas & Fischbach, “The number of Na+channels in cultured chick muscle is increased by ARIA, an acetylcholine receptor-inducing activity”J. Neuroscience13(5):2118-2125 (1993).
Danilenko et al., “Neu differentiation factor (NDF) accelerates epidermal migration and differentiation in excisional wounds”FASEB8(4-5):abst No. 3101, p A535 (1994).
Falls et al., “ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of Neu ligand family”Cell72:801-815 (1993).
Fendly, B.M. et al., “Characterization of Murine Monclonal Antibodies Reactive to Either the Human Epidermal Growth Factor Receptor or HER2
eu Gene Product”Cancer Research50:1550-1558 (Mar. 1, 1990).
Friess et al., “Enhanced erbB-3 Expression in Human Pancreatic Cancer Correlates with Tumor Progression”Clinical Cancer Research1:1413-1420 (1995).
Gorman et al., “Transient Production of Proteins Using an Adenovirus Transformed Cell Line”DNA Prot. Eng. Tech. 2(1):3-10 (1990).
Ho, W., et al., “Sensory and Motor Neuron-derived Factor”Journal of Biological Chemistry270(24):14523-14532 (Jun. 16, 1995).
Holmes et al., “Identification of Heregulin, A Specific Activator of p185erbB2”Science256:1205-1210 (May 22, 1992).
Huang et al., “Intervening Sequences Increases Efficiency of RNA 3′ Processing and Accumulation of Cytoplasmic RNA.”Nucleic Acids Research, 18(4):937-947 (Feb. 25, 1990).
King et al., “Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2
eu proto-oncogene product is induced by hyperosmotic shock”Oncogene4(1):13-18 (Jan. 1989).
Kokai et al., “Synergistic Interaction of p185c-neu and the EGF Receptor Leads to Transformation of Rodent Fibroblasts”Cell58:287-292 (Jul. 28, 1989).
Kozak, “An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs”Nucleic Acids Research15(20):8125-8148 (Oct. 26, 1987).
Kraus et al., “Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells,”Proc. Natl. Acad. Sci. 90:2900-2904 (1993).
Kraus et al., “Isolation and Characterization of ERBB3, A Third Member of the ERBB/Epidermal Growth Factor Receptor Family: Evidence for Overexpression in a Subset of Human Mammary Tumors”Proc. Natl. Acid Sci. USA86:9193-9197 (Dec. 1989).
Kung et al., “Isolation of a heregulin-like growth factor secreted by estrogen receptor-negative MDA-MB-231 human breast cancer cells that stimulates estrogen receptor-positive cells”Biochem.&Biophys. Res. Commun. 202(3):1357-1365 (Aug. 15, 1994).
Kunkel, T., “Rapid and Efficient Site-Specific Mutagenesis Without Phenotypic Selection”Proc. Natl. Acad. Sci. 82:488-492 (1985).
LaVallie et al., “A thioredoxin gene fusion expression system that circumvents inclusion body formation in theE. colicytoplasm”Bio/Technology11(2):187-193 (Feb. 1993).
Lemke & Brockes, “Identification and purification of glial growth factor”J. Neurosci. 4(1):75-83 (1984).
Lemoine et al., “Expression of the ERBB3 gene product in breast cancer”Br. J. Cancer66:1116-1121 (1992).
Lemoine et al., “The erbB-3 gene in human pancreatic cancer”J. Pathol. 168:269-273 (1993).
Levi et al., “The functional characteristics of Schwann Cells cultured from human peripheral nerve after transplantation into a gap within the rat sciatic nerve”J. Neuroscience14(3):1309-1319 (1994).
Lewis et al., “Differential Response of Human Tumor Cell Lines to Anti-p185HER2Monoclonal Antibodies.”Cancer Immunol. Immunother. 37:255-263 (1993).
Li et al., “Identification of Gas6 as a Growth Factor for Human Schwann Cells”The Journal of Neuroscience16(6):2012-2019 (Mar. 15, 1996).
Liu et al., “y-Heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation”Oncogene18:7110-7114 (1999).
Marchionni et al., “Glial growth factors are alternatively spliced erbB2 ligand expressed in the nervous system”Nature362:312-318 (1993).
Meyer & Birchmeier, “Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development”Proc. Natl. Acad. Sci. 91:1064-1068 (1994).
Orr-Urtreger et al., “Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21”Proc. Natl. Acad. Sci. USA90:1867-1871 (1993).
Peles et al., “Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships”EMBO Journal12(3):961-971 (1993).
Peles et al., “Isolation of the Neu/HER-2 Stimulatory Ligand: A 44 Kd Glycoprotein that Induces Differentiation of Mammary Tumor Cells”Cell69(1):205-216 (1992).
Pinkas-Kramarski et al., “Brain neurons and glial cells express Neu differentiation factor/heregulin: A survival factor for astrocytes”Proc. Natl. Acad. Sci. USA91:9387-9391 (1994).
Plowman et al., “Heregulin Induces Tyrosine Phosphorylation of HER4/p180erbB4”Nature(Letters to Nature) 366:473-475 (Dec. 2, 1993).
Plowman

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antibodies that bind gamma-heregulin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies that bind gamma-heregulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind gamma-heregulin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3425352

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.